Company · CIK 0001815776 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
LENZ Therapeutics, Inc. · LENZ
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 AForm 4 → | Jun 15, 8:22 pm EDT | RA CAPITAL MANAGEMENT, L.P. +4Director, 10% Owner | 22,100 | — | — | 22,100 | — | |
| Jun 15, 2026 AForm 4 → | Jun 15, 8:18 pm EDT | Jeffrey P. GeorgeDirector | 22,100 | — | — | 22,100 | — | |
| Jun 15, 2026 AForm 4 → | Jun 15, 8:18 pm EDT | Kimberlee C DrapkinDirector | 22,100 | — | — | 22,100 | — | |
| Jun 15, 2026 AForm 4 → | Jun 15, 8:18 pm EDT | James W McCollumDirector | 22,100 | — | — | 22,100 | — | |
| Jun 15, 2026 AForm 4 → | Jun 15, 8:18 pm EDT | Shelley B ThunenDirector | 22,100 | — | — | 22,100 | — | |
| Jun 15, 2026 AForm 4 → | Jun 15, 8:18 pm EDT | Frederic GuerardDirector | 22,100 | — | — | 22,100 | — | |
| Jun 15, 2026 AForm 4 → | Jun 15, 8:17 pm EDT | Zachary ScheinerDirector | 22,100 | — | — | 22,100 | — |